NFX — Nuformix Share News
0.000.00%
Last trade - 00:00Holding(s) in Company
NXP002 Completion of Tolerability Studies
Posting of Annual Report and Notice of AGM
Board Changes
Annual Results for the year ended 31 March 2022
Brief: Nuformix Says NXP002 Data To Be Presented At 2022 European Respiratory Society Congress
NXP002 data to be presented at 2022 ERS Congress
Brief: Nuformix Provides Update In Relation To Company's Nxp004 Programme
NXP004 Update
Brief: Nuformix Says NXP002 Formulations For Nebulisation Can Be Efficiently Delivered To Lung
NXP002 Update
Holding(s) in Company
Brief: Nuformix Says Executive Chairman Alastair Riddell Resigns
Directorate Change
Corporate Update
Second tranche of Lanstead subscription shares
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company